The basics in plain language
ADHD medication doesn't give you focus you didn't have. It adjusts the neurochemistry so your existing focus system works more reliably. Think of it less like adding a turbocharger and more like adjusting the idle speed on an engine that stalls at every stoplight.
The two main neurotransmitters involved are dopamine and norepinephrine. Both play roles in attention, motivation, and executive function. In ADHD, signaling through these pathways is less efficient, particularly in the prefrontal cortex, the brain's control center for planning, prioritization, and impulse control.
How stimulants work
Stimulant medications (methylphenidate-based like Ritalin and Concerta, or amphetamine-based like Adderall and Vyvanse) increase dopamine and norepinephrine availability in the synaptic cleft. They do this by blocking reuptake transporters, which are proteins that normally vacuum these neurotransmitters back into the releasing neuron.
Volkow et al. (2009) showed that ADHD brains have higher concentrations of dopamine transporters, meaning dopamine gets recycled too quickly. Stimulants slow this recycling, keeping dopamine available longer. This is why the name "stimulant" is misleading: in ADHD brains, these medications don't create overstimulation. They normalize an underactive signaling system.
Stimulants work for about 70-80% of people with ADHD. When the first stimulant class doesn't work, switching to the other (methylphenidate to amphetamine or vice versa) often does. Effect onset is fast, typically within 30-60 minutes, and wears off within 4-12 hours depending on the formulation.
How non-stimulants work
Non-stimulant options include atomoxetine (Strattera), guanfacine (Intuniv), and viloxazine (Qelbree). These work differently:
- Atomoxetine selectively blocks norepinephrine reuptake. It takes 4-6 weeks to reach full effect, more like an antidepressant timeline. It provides 24-hour coverage without abuse potential.
- Guanfacine is an alpha-2 adrenergic agonist. It works on receptors in the prefrontal cortex to improve working memory and reduce impulsivity. Often used as an add-on to stimulants.
- Viloxazine affects both norepinephrine and serotonin. Newer to the market, it provides another non-stimulant option with a different side effect profile.
What medication doesn't do
Medication doesn't fix ADHD. It reduces symptoms while it's active, creating a window where behavioral strategies, environmental design, and skill-building become more effective. Safren et al. (2010) showed that CBT combined with medication produced better outcomes than either alone.
Medication also doesn't tell you what to focus on. Many people report that stimulants can make them hyperfocus on the wrong thing (deep-cleaning the kitchen instead of finishing the report). External systems for prioritization, like UpOrbit's must-do feature, help direct the improved focus toward what actually matters.
Finding the right fit
- Expect some trial and error. The first medication and dose aren't always right. Most prescribers start low and increase gradually.
- Track your response. Note when the medication kicks in, when it wears off, side effects, mood changes, and appetite. Concrete data helps your prescriber adjust effectively.
- Extended-release vs. immediate-release matters for coverage throughout the day. Some people do best with an extended-release morning dose plus an immediate-release booster in the afternoon.
- Don't compare your dose to others. Effective doses vary widely based on individual metabolism, not severity of ADHD.
If tracking how your medication is working helps you have better conversations with your prescriber, try UpOrbit. It's free, private, and can help you spot patterns over time.
References
- Volkow et al. (2009). Dopamine reward pathway in ADHD. JAMA, 302(10), 1084-1091.
- Safren et al. (2010). CBT for adult ADHD. JAMA, 304(8), 875-880.